First experience with a new drug-eluting balloon for the treatment of congenital pulmonary vein stenosis in a neonate.
Paclitaxel-eluting balloons are a new and innovative method in the treatment of in-stent stenosis and small vessel disease in adult cardiac pathology. The treatment of congenital pulmonary vein stenosis is difficult to manage, and results in a high mortality rate due to residual or recurrent stenosis. We report the first case of treatment for neonatal pulmonary vein restenosis with a paclitaxel-eluting balloon.
Mueller
Goetz Christoph
GC
Department of Paediatric Cardiology, University Heart Center Hamburg, Hamburg, Germany. go.mueller@uke.uni-hamburg.de
Dodge-Khatami
Ali
A
Weil
Jochen
J
D000367:Age Factors; D002404:Catheterization / Q000295:instrumentation*; D054855:Drug-Eluting Stents; D006801:Humans; D007231:Infant, Newborn; D017239:Paclitaxel / Q000009:adverse effects; D011666:Pulmonary Valve Stenosis / Q000151:congenital* / Q000175:diagnosis / Q000628:therapy*; D050257:Tubulin Modulators / Q000009:adverse effects
D050257:Tubulin Modulators; D017239:Paclitaxel